Aortic & peripheral vascular diseaseCohort study
Cardiovascular risk among giant cell arteritis patients
- Retrospective cohort study
- propensity-score matched
- French National Health Data System (SNDS)
Authors' conclusion
GCA significantly increases risks of vascular complications
Study context
- Population
- Patients aged ≥50 years with incident giant cell arteritis, France, 2012–2022
- Participants
- 23,193 / 92,772 / 92,772
- Exposure
- Giant cell arteritis (GCA) vs matched general population and hospitalized cohorts
- GCAn = 23,193
- General populationn = 92,772reference
- Hospitalizedn = 92,772reference
- Outcome
- First incidence of aortic events, MACE, peripheral artery disease (PAD) events and visceral artery events
Main finding
As reported in the abstract
Hazard ratio (95% CI)
GCA vs General populationaortic events
5.33(4.50–6.32)
GCA vs General populationMACE
2.15(2.04–2.26)
GCA vs General populationPAD events
2.72(2.47–2.99)
GCA vs General populationvisceral artery events
3.04(2.33–3.97)
GCA vs HospitalizedMACE, not significantly different
1.01(0.96–1.06)
Observational data: associations, not effects.
Further findings
Major adverse cardiovascular events (MACE) by GCA disease activity
- GCA disease activity associated with increased MACE (HR)
- 1.98 (95% CI 1.63-2.42)
Original publication
Cardiovascular risk among giant cell arteritis patients. Eur J Prev Cardiol. Published 14 January 2026. doi:10.1093/eurjpc/zwag034
Summarised from the published abstract; every number is checked against it